• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation.缺乏护理人员与接受自体干细胞移植的骨髓瘤患者的生存时间更短有关。
Leuk Lymphoma. 2022 Oct;63(10):2422-2427. doi: 10.1080/10428194.2022.2074993. Epub 2022 May 12.
2
Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.评价多发性骨髓瘤患者门诊自体干细胞移植后未计划入院率的表现状态和造血细胞移植特异性合并症指数。
Biol Blood Marrow Transplant. 2017 Oct;23(10):1641-1645. doi: 10.1016/j.bbmt.2017.06.001. Epub 2017 Jun 8.
3
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.多发性骨髓瘤患者的住院与门诊自体造血干细胞移植比较。
Eur J Haematol. 2017 Dec;99(6):532-535. doi: 10.1111/ejh.12970. Epub 2017 Oct 8.
4
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.自体-异体造血干细胞移植序贯治疗多发性骨髓瘤的长期随访。
Haematologica. 2019 Feb;104(2):380-391. doi: 10.3324/haematol.2018.200253. Epub 2018 Sep 27.
5
The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation.多发性骨髓瘤患者行门诊自体干细胞移植与住院移植相比,照料者的负担。
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e402-e409. doi: 10.1016/j.clml.2020.11.011. Epub 2020 Nov 20.
6
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.接受大剂量化疗和自体造血干细胞移植的高危和标危多发性骨髓瘤患者的治疗结果
Clin Lymphoma Myeloma Leuk. 2015 Nov;15(11):687-93. doi: 10.1016/j.clml.2015.07.641. Epub 2015 Aug 5.
7
Knowing the unknowns in high risk multiple myeloma.了解高危多发性骨髓瘤中的未知因素。
Blood Rev. 2022 Jan;51:100887. doi: 10.1016/j.blre.2021.100887. Epub 2021 Aug 28.
8
Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma.自体干细胞移植对多发性骨髓瘤患者长期肾功能的影响及其与无进展生存和总体生存的关系。
Leuk Lymphoma. 2020 Dec;61(13):3101-3111. doi: 10.1080/10428194.2020.1797719. Epub 2020 Jul 29.
9
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.自体造血干细胞移植对比硼替佐米-美法仑-泼尼松(联合或不联合硼替佐米-来那度胺-地塞米松巩固治疗)以及来那度胺维持治疗用于新诊断的多发性骨髓瘤(EMN02/HO95):一项多中心、随机、开放标签的3期研究
Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30.
10
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents.自体干细胞移植治疗新型药物治疗的≥75 岁多发性骨髓瘤患者。
Bone Marrow Transplant. 2021 May;56(5):1144-1150. doi: 10.1038/s41409-020-01159-9. Epub 2020 Dec 4.

引用本文的文献

1
The Caregiver Paradigm in Hematopoietic Cell Transplant: Current and Future Directions.造血细胞移植中的照护者模式:现状与未来方向
Transplant Cell Ther. 2025 Jun 20. doi: 10.1016/j.jtct.2025.06.022.
2
Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective.多发性骨髓瘤自体干细胞移植经验:患者及照顾者视角
J Patient Exp. 2023 Sep 25;10:23743735231202733. doi: 10.1177/23743735231202733. eCollection 2023.
3
A Mixed-Methods Feasibility Study: Eliciting ICU Experiences and Measuring Outcomes of Family Caregivers of Patients Who Have Undergone Hematopoietic Stem Cell Transplantation.一项混合方法可行性研究:了解重症监护病房经验并衡量接受造血干细胞移植患者的家庭照护者的结局。
J Fam Nurs. 2023 Aug;29(3):227-247. doi: 10.1177/10748407231166945. Epub 2023 May 16.

本文引用的文献

1
The effect of marital status on the survival of patients with multiple myeloma.婚姻状况对多发性骨髓瘤患者生存的影响。
Hematology. 2022 Dec;27(1):187-197. doi: 10.1080/16078454.2022.2026027.
2
Socioeconomic Factors and Survival of Multiple Myeloma Patients.社会经济因素与多发性骨髓瘤患者的生存情况
Cancers (Basel). 2021 Feb 3;13(4):590. doi: 10.3390/cancers13040590.
3
Education level as a predictor of survival in patients with multiple myeloma.教育水平对多发性骨髓瘤患者生存的预测作用。
BMC Cancer. 2020 Aug 8;20(1):737. doi: 10.1186/s12885-020-07178-5.
4
A conceptual model of social networks and mechanisms of cancer mortality, and potential strategies to improve survival.社会网络与癌症死亡率的作用机制及其提高生存率的潜在策略的概念模型。
Transl Behav Med. 2018 Jul 17;8(4):629-642. doi: 10.1093/tbm/ibx061.
5
Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma.自体造血干细胞移植治疗多发性骨髓瘤的安全性结局。
Mayo Clin Proc. 2018 Jan;93(1):56-58. doi: 10.1016/j.mayocp.2017.09.012.
6
Social integration and survival after diagnosis of colorectal cancer.结直肠癌诊断后的社会融合与生存。
Cancer. 2018 Feb 15;124(4):833-840. doi: 10.1002/cncr.31117. Epub 2017 Nov 21.
7
Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.标准风险多发性骨髓瘤患者临床预后较差的预测因素。
Eur J Haematol. 2017 Mar;98(3):263-268. doi: 10.1111/ejh.12826. Epub 2016 Dec 1.
8
Associations between advanced cancer patients' survival and family caregiver presence and burden.晚期癌症患者的生存与家庭照顾者的陪伴及负担之间的关联。
Cancer Med. 2016 May;5(5):853-62. doi: 10.1002/cam4.653. Epub 2016 Feb 10.
9
The poorer cancer survival among the unmarried in Norway: is much explained by comorbidities?挪威单身人群癌症存活率较低:是否主要由合并症导致?
Soc Sci Med. 2013 Mar;81:42-52. doi: 10.1016/j.socscimed.2013.01.012. Epub 2013 Jan 21.
10
Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone.独居转移性结直肠癌患者的治疗强度较低,生存状况较差。
Br J Cancer. 2012 Jun 26;107(1):189-94. doi: 10.1038/bjc.2012.186. Epub 2012 May 10.

缺乏护理人员与接受自体干细胞移植的骨髓瘤患者的生存时间更短有关。

Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation.

机构信息

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

出版信息

Leuk Lymphoma. 2022 Oct;63(10):2422-2427. doi: 10.1080/10428194.2022.2074993. Epub 2022 May 12.

DOI:10.1080/10428194.2022.2074993
PMID:35549799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9679915/
Abstract

There is increasing evidence that social infrastructure and a healthy social network can improve cancer survival. Mayo Clinic has an outpatient stem cell transplantation program for myeloma. Safe outpatient transplantation requires a caregiver to be present. Patients lacking a caregiver are transplanted as an inpatient. We reviewed outcomes on over 2000 patients with multiple myeloma, 2103 transplanted as an outpatient compared with 41 hospitalized for transplantation. Although progression-free survival following transplantation was identical between the two groups, overall survival was shorter in those hospitalized. This suggests that the absence of a caregiver for transplantation is an important surrogate of the social infrastructure associated with poor outcomes in transplanted patients with multiple myeloma.

摘要

越来越多的证据表明,社会基础设施和健康的社交网络可以改善癌症患者的生存率。梅奥诊所(Mayo Clinic)有一个多发性骨髓瘤的门诊干细胞移植项目。安全的门诊移植需要有护理人员在场。没有护理人员的患者则作为住院患者进行移植。我们回顾了 2000 多名多发性骨髓瘤患者的结果,其中 2103 名患者作为门诊患者进行移植,41 名患者住院进行移植。尽管两组患者在移植后的无进展生存率相同,但住院患者的总生存率较低。这表明,移植时没有护理人员,这是与多发性骨髓瘤移植患者不良预后相关的社会基础设施缺失的一个重要替代指标。